Improving heart and kidney treatment for patients with diabetes
Official title: Closing the Cardio-Renal Preventive Treatment Gap Among Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease: An Implementation Science Approach
Funded at University of California, San Francisco · NIH-11015914 · Data updated 2026-11-12
This study is looking into why people with type 2 diabetes and chronic kidney disease aren't getting the heart-protecting treatments they need, and it aims to find ways to make sure these important medications are prescribed more often.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | February 1, 2024 |
| Project end | January 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $248,723 |
| NIH project number | 5R00HL157721-04 |
| Project ID | NIH-11015914 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with type 2 diabetes mellitus and chronic kidney disease.
✕Less likely to help
Patients without diabetes or kidney disease, or those who are not at risk for cardiovascular disease may not benefit from this research.
What this research studies
This research investigates why patients with type 2 diabetes and chronic kidney disease are not receiving effective treatments that can prevent cardiovascular disease. By analyzing a large dataset of over 1.5 million patients and conducting focus groups with both patients and healthcare providers, the study aims to identify barriers to the prescription of essential therapies. The goal is to understand the factors that contribute to the under-prescription of these life-saving medications and to develop strategies to improve their use in clinical practice.
Why it matters
Potential benefit: If successful, this research could lead to better management of cardiovascular risks in patients with diabetes and chronic kidney disease, ultimately improving their health outcomes.
How similar studies have gone: Previous research has shown that addressing barriers to medication adherence can significantly improve patient outcomes, suggesting that this approach may also be effective.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Lamprea Montealegre, Julio Alejandro — University of California, San Francisco
- Study coordinator: Lamprea Montealegre, Julio Alejandro
Related research
Other NIH-funded projects on the same topics.
-
Improving heart- and kidney-protective treatment for people with type 2 diabetes and chronic kidney disease
This project will help people with type 2 diabetes and chronic kidney disease get proven medicines that protect the heart and kidneys but are often missed.
-
Exploring new muscle chemistry in adults with Type 2 diabetes
A study will test a new imaging method to measure muscle metabolites in adults with Type 2 diabetes to better understand how the disease affects their muscles.
-
Save with Care: Help with costs to manage type 2 diabetes
A digital program helps adults with type 2 diabetes on high-deductible plans save money and get better access to care.
-
Predicting obesity-related diabetes and wound healing with math models
A math-based model is being built to better understand how obesity drives type 2 diabetes and slow wound healing in adults.
-
Rapid, multi-drug initiation for people with CKD and type 2 diabetes
A small study will try starting several key diabetes and kidney medicines at the same time in adults with CKD and type 2 diabetes to see if this fast plan is safe and helpful.
-
Personalized nutrition guided by continuous glucose monitors for type 2 diabetes
See whether using continuous glucose monitors to tailor meals helps adults with type 2 diabetes keep blood sugar under better control.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.